In this blog post our CEO offers some opinions on UK Research and Innovation's strategy. This was first published by the BioIndustry Association.
In this blog, learn about current challenges of hiPSC-derived cell models, best approach for cell generation & future trends for human cell models.
Our CEO writes about the importance of the synthetic biology industry as part of the UK Life Sciences vision. This was first published by the BioIndustry Association.
Our CEO reflects on a recent UN High-Level Political Forum discussion about industry & academia collaborations to achieve sustainable development goals.
Our CEO explains how our opti-ox technology underpins not only bit.bio but also Meatable - a cultured meat company — and why we need to rethink sustainability.